Cognizant Technology Solutions Stock News

Reinhart Partners Inc. cut its stake in Cognizant Technology Solutions Co. (NASDAQ:CTSH) by 9.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 276,946 shares of the information technology service providers stock after selling 27,505 shares during the period. Reinhart []

Albion Financial Group UT increased its holdings in shares of Cognizant Technology Solutions Co. (NASDAQ:CTSH) by 2.2% during the 3rd quarter, Holdings Channel.com reports. The fund owned 11,877 shares of the information technology service providers stock after acquiring an additional 252 shares during the period. Albion Financial Group UTs holdings in Cognizant Technology Solutions were []

Raymond James Trust N.A. increased its position in Cognizant Technology Solutions Co. (NASDAQ:CTSH) by 2.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,921 shares of the information technology service providers stock after acquiring an additional 388 shares during the period. Raymond James []

Raymond James Trust N.A. increased its position in Cognizant Technology Solutions Co. (NASDAQ:CTSH) by 2.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,921 shares of the information technology service providers stock after acquiring an additional 388 shares during the period. Raymond James []

Symmetry Partners LLC decreased its holdings in shares of Cognizant Technology Solutions Co. (NASDAQ:CTSH) by 23.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,738 shares of the information technology service providers stock after selling 2,364 shares during the []

Achal Kataria has joined Cognizant as the vice president and country head (India). Kataria succeeded Anantharaman

There is a demand level unlike anything we have ever seen in many, many years: Cognizant CEO Brian Humphries

Latest published market study on Health Care IT Market provides an overview of the current market dynamics in the Health Care IT space, as well as what our survey respondentsall outsourcing decision-makerspredict the market will look like in 2027. The

Brokerages forecast that Cognizant Technology Solutions Co. (NASDAQ:CTSH) will announce earnings of $1.03 per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Cognizant Technology Solutions earnings. The highest EPS estimate is $1.07 and the lowest is $0.95. Cognizant Technology Solutions reported earnings per share of $0.67 during []

Cognizant is investing heavily to expand its presence in IoT, AI, Cloud, and Software engineering fields. The company is continuously improving its free cash flow yield.

Wall Street brokerages predict that Cognizant Technology Solutions Co. (NASDAQ:CTSH) will post sales of $4.78 billion for the current quarter, Zacks Investment Research reports. Six analysts have made estimates for Cognizant Technology Solutions earnings, with the highest sales estimate coming in at $4.81 billion and the lowest estimate coming in at $4.73 billion. Cognizant Technology []

Unigestion Holding SA trimmed its holdings in Cognizant Technology Solutions Co. (NASDAQ:CTSH) by 47.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,878 shares of the information technology service providers stock after selling 7,217 shares during the quarter. Unigestion []

Newfound Research LLC grew its holdings in Cognizant Technology Solutions Co. (NASDAQ:CTSH) by 36.4% during the 3rd quarter, Holdings Channel reports. The firm owned 1,004 shares of the information technology service providers stock after buying an additional 268 shares during the period. Newfound Research LLCs holdings in Cognizant Technology Solutions were worth $75,000 at the []

In life sciences, research and development BPO services include biometric, competitive intelligence pipeline research, R&D portfolio management, and more. Furthermore, drug development services include clinical data management, regulatory services, and pharmacovigiliance. The global life sciences BPO market is projected to